https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accelerated-share-repurchases-final-price-paid-per-share https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accrual-provision https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability-1 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/advances-on-inventory-purchases https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/area-of-real-estate-property https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-loss-before-tax https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain-loss-1 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/business-acquisition-contingent-consideration-at-fair-value-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/business-acquisition-contingent-consideration-at-fair-value-noncurrent https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-default-longterm-debt-amount https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-issuance-costs https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-next-rolling-twelve-months https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-rolling-year-two https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-periodic-payment https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-periodic-payment-interest https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/deferred-tax-liabilities-deferred-expense-capitalized-research-and-development-costs https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/fair-value-liabilities-obligations https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/gains-losses-on-restructuring-of-debt https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/insider-transactions-stock-options/sales https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-noncurrent-fair-value-disclosure https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/investment-warrants-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/level-3-liability-settlements https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/liabilities-fair-value-disclosure-recurring https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/manufacturing-costs https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/marketable-securities-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/notes-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/notes-reduction https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-leases-income-statement-lease-revenue https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/other-liabilities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/other-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/paid-in-capital-share-based-compensation-employee-stock-purchase-program-requisite-service-period-recognition https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/paid-in-capital-stock-split https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/patents-active https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/payments-to-acquire-additional-interest-in-subsidiaries https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/production-related-impairments-or-charges https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/repayment-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/research-and-development-in-process https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/restricted-cash-and-investments-current https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sales-revenue-net https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-defr14a https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/sec-filings-sd https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/secured-debt https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/shares-outstanding-2 https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/short-term-debt https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-per-share-weighted-average-price-of-shares-purchased https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-outstanding-change https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tangible-asset-impairment-charges https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/unrealized-gain-on-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/unrealized-loss-on-securities https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/alexza-pharmaceuticals-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation